Kintara Therapeutics, Inc. (NASDAQ:KTRA) Short Interest Up 390.4% in March
Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 25,500 shares, a growth of 390.4% from the March 15th total of 5,200 shares. Approximately 1.6% of the shares of the stock are sold short. Based on […]